{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:43:54Z","timestamp":1792269834715,"version":"4.4.0"},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ejim.2026.107229","type":"journal-article","created":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:03:05Z","timestamp":1792267385000},"page":"107229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Abatacept in RA-ILD: further clarification of the potential pulmonary window of opportunity"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-0679-3766","authenticated-orcid":false,"given":"Ana","family":"Serrano-Combarro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adri\u00e1n","family":"Mart\u00edn-Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bel\u00e9n","family":"Atienza-Mateo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2344-2285","authenticated-orcid":false,"given":"Ricardo","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2026.107229_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejim.2026.106997","article-title":"Window of opportunity with abatacept in rheumatoid arthritis-associated interstitial lung disease: a multicentre study of 526 patients","author":"Serrano-Combarro","year":"2026","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2026.107229_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejim.2026.107105","article-title":"Abatacept in RA-ILD: defining rather than assuming a pulmonary window of opportunity","author":"Kong","year":"2026","journal-title":"Eur J Intern Med"},{"issue":"2","key":"10.1016\/j.ejim.2026.107229_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103501","article-title":"Does a window of opportunity for rheumatoid arthritis-associated interstitial lung disease exist?","volume":"23","author":"Akiyama","year":"2024","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.ejim.2026.107229_bib0004","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00016-2016","article-title":"ERS\/ATS standards for single-breath carbon monoxide uptake in the lung","volume":"49","author":"Graham","year":"2017","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.ejim.2026.107229_bib0005","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.chest.2024.10.052","article-title":"Quantitative CT scan analysis in rheumatoid arthritis-related interstitial lung disease","volume":"167","author":"Humphries","year":"2025","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.ejim.2026.107229_bib0006","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.58192","article-title":"Target trial emulation: a unifying approach for causal inference from observational data","volume":"9","author":"Simon-Tillaux","year":"2026","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ejim.2026.107229_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2024.152517","article-title":"Subcutaneous vs intravenous abatacept in rheumatoid arthritis-interstitial lung disease: national multicentre study of 397 patients","volume":"68","author":"L\u00f3pez-Maraver","year":"2024","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.ejim.2026.107229_bib0008","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejim.2023.08.025","article-title":"Abatacept in usual and in non-specific interstitial pneumonia associated with rheumatoid arthritis","volume":"119","author":"Atienza-Mateo","year":"2024","journal-title":"Eur J Intern Med"},{"issue":"1","key":"10.1016\/j.ejim.2026.107229_bib0009","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/rheumatology\/keab317","article-title":"Abatacept in monotherapy versus combined therapy in interstitial lung disease of rheumatoid arthritis: multicentre study of 263 Caucasian patients","volume":"61","author":"Fern\u00e1ndez-D\u00edaz","year":"2021","journal-title":"Rheumatology"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620526005340?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620526005340?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:03:07Z","timestamp":1792267387000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620526005340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":9,"alternative-id":["S0953620526005340"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2026.107229","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Abatacept in RA-ILD: further clarification of the potential pulmonary window of opportunity","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2026.107229","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Federation of Internal Medicine. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107229"}}